Skip to main content

IFA

Neurological autoimmune diseases require precise laboratory diagnostics, as they are often associated with complex and heterogeneous clinical symptoms. The detection of specific autoantibodies plays a key role in diagnosis, differentiation, and disease monitoring. Our IFA portfolio for neurology consists of immunofluorescence assays for the qualitative and semi-quantitative detection of relevant autoantibodies. These tests support laboratories in the reliable identification of neurological autoimmune disorders and integrate easily into routine diagnostic workflows. They provide clear and reproducible results for confident diagnostic evaluation.
Contact us